Literature DB >> 6167328

Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice.

J L Hylden, G L Wilcox.   

Abstract

Intrathecal injection of substance P in mice elicited a dose-related biting and scratching response. Systemic but not intrathecal morphine sulfate antagonized this response. We interpret these observations to define a novel nociceptive response to intrathecal substance P.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6167328     DOI： 10.1016/0006-8993(81)90203-1

Source DB:  PubMed          Journal:  Brain Res        ISSN： 0006-8993            Impact factor:   3.252


  59 in total

1.  Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.

Authors:  Arpad Dobolyi; Hiroshi Ueda; Hitoshi Uchida; Miklós Palkovits; Ted B Usdin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.

Authors:  L S Stone; L B MacMillan; K F Kitto; L E Limbird; G L Wilcox
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  Inflammation increases the distribution of dorsal horn neurons that internalize the neurokinin-1 receptor in response to noxious and non-noxious stimulation.

Authors:  C Abbadie; J Trafton; H Liu; P W Mantyh; A I Basbaum
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.

Authors:  T M Largent-Milnes; T Yamamoto; P Nair; J W Moulton; V J Hruby; J Lai; F Porreca; T W Vanderah
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

5.  Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.

Authors:  Maureen S Riedl; Patrick D Braun; Kelley F Kitto; Samuel A Roiko; Lorraine B Anderson; Christopher N Honda; Carolyn A Fairbanks; Lucy Vulchanova
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

6.  Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.

Authors:  T Sakurada; S Katsuyama; S Sakurada; M Inoue; K Tan-No; K Kisara; C Sakurada; H Ueda; J Sasaki
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

7.  Pharmacological characterization of tachykinin tetrabranched derivatives.

Authors:  Chiara Ruzza; Anna Rizzi; Davide Malfacini; Maria Camilla Cerlesi; Federica Ferrari; Erika Marzola; Caterina Ambrosio; Cristina Gro; Salvadori Severo; Tommaso Costa; Girolamo Calo; Remo Guerrini
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

8.  A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype.

Authors:  Anne-Marie Malfait; Albert B Seymour; Feng Gao; Micky D Tortorella; Marie-Pierre Hellio Le Graverand-Gastineau; Linda S Wood; Michael Doherty; Sally Doherty; Weiya Zhang; Nigel K Arden; Frances L Vaughn; Paul E Leaverton; Tim D Spector; Deborah J Hart; Rose A Maciewicz; Kenneth R Muir; Rosalina Das; Robert E Sorge; Susanna G Sotocinal; Ara Schorscher-Petcu; Ana M Valdes; Jeffrey S Mogil
Journal:  Ann Rheum Dis       Date:  2012-03-22       Impact factor: 19.103

9.  Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.

Authors:  Suzanne Doolen; Jennifer Cook; Maureen Riedl; Kelley Kitto; Shinichi Kohsaka; Christopher N Honda; Carolyn A Fairbanks; Bradley K Taylor; Lucy Vulchanova
Journal:  Glia       Date:  2017-08-29       Impact factor: 7.452

10.  Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.

Authors:  Anne-Julie Chabot-Doré; Magali Millecamps; Lina Naso; Dominic Devost; Phan Trieu; Marjo Piltonen; Luda Diatchenko; Carolyn A Fairbanks; George L Wilcox; Terence E Hébert; Laura S Stone
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.